The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Tumour-associated macrophages secrete pleiotrophin to promote PTPRZ1 signalling in glioblastoma stem cells for tumour growth
Open accessAbstract
Intense infiltration of tumour-associated macrophages (TAMs) facilitates malignant growth of glioblastoma (GBM), but the underlying mechanisms remain undefined. Herein, we report that TAMs secrete abundant pleiotrophin (PTN) to stimulate glioma stem cells (GSCs) through its receptor PTPRZ1 thus promoting GBM malignant growth through PTN–PTPRZ1 paracrine signalling. PTN expression correlates with infiltration of CD11b+/CD163+ TAMs and poor prognosis of GBM patients. Co-implantation of M2-like macrophages (MLCs) promoted GSC-driven tumour growth, but silencing PTN expression in MLCs mitigated their pro-tumorigenic activity. The PTN receptor PTPRZ1 is preferentially expressed in GSCs and also predicts GBM poor prognosis. Disrupting PTPRZ1 abrogated GSC maintenance and tumorigenic potential. Moreover, blocking the PTN–PTPRZ1 signalling by shRNA or anti-PTPRZ1 antibody potently suppressed GBM tumour growth and prolonged animal survival. Our study uncovered a critical molecular crosstalk between TAMs and GSCs through the PTN–PTPRZ1 paracrine signalling to support GBM malignant growth, indicating that targeting this signalling axis may have therapeutic potential.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stupp, R., Hegi, M. E., Mason, W. P., van den Bent, M. J., Taphoorn, M. J., Janzer, R. C., Ludwin, S. K., Allgeier, A., Fisher, B., Belanger, K., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70025-7 · Cited by 7,668
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., & Rich, J. N. (2006) · Nature · doi:10.1038/nature05236 · Cited by 6,379
Self-citationMANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
Tumor-Associated Macrophages: From Mechanisms to Therapy
Noy, R., & Pollard, J. W. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.010 · Cited by 4,089
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
Grauer, O. M., Wesseling, P., & Adema, G. J. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00315.x · Cited by 4,007
Camp, R. L., Dolled-Filhart, M., & Rimm, D. L. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0713 · Cited by 3,744
Java Treeview—extensible visualization of microarray data
Saldanha, A. J. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth349 · Cited by 2,991
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
Pyonteck, S. M., Akkari, L., Schuhmacher, A. J., Bowman, R. L., Sevenich, L., Quail, D. F., Olson, O. C., Quick, M. L., Huse, J. T., Teijeiro, V., et al. (2013) · Nature Medicine · doi:10.1038/nm.3337 · Cited by 2,463
A Perivascular Niche for Brain Tumor Stem Cells
Calabrese, C., Poppleton, H., Kocak, M., Hogg, T. L., Fuller, C., Hamner, B., Oh, E. Y., Gaber, M. W., Finklestein, D., Allen, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.020 · Cited by 2,197
Hu, Y., & Smyth, G. K. (2009) · Journal of Immunological Methods · doi:10.1016/j.jim.2009.06.008 · Cited by 2,083
The role of microglia and macrophages in glioma maintenance and progression
Hambardzumyan, D., Gutmann, D. H., & Kettenmann, H. (2016) · Nature Neuroscience · doi:10.1038/nn.4185 · Cited by 1,683
Macrophages and Therapeutic Resistance in Cancer
Ruffell, B., & Coussens, L. M. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.02.015 · Cited by 1,474
Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells
Li, Z., Bao, S., Wu, Q., Wang, H., Eyler, C., Sathornsumetee, S., Shi, Q., Cao, Y., Lathia, J., McLendon, R. E., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.03.018 · Cited by 1,354
Self-citationReconstructing and Reprogramming the Tumor-Propagating Potential of Glioblastoma Stem-like Cells
Suvà, M. L., Rheinbay, E., Gillespie, S. M., Patel, A. P., Wakimoto, H., Rabkin, S. D., Riggi, N., Chi, A. S., Cahill, D. P., Nahed, B. V., et al. (2014) · Cell · doi:10.1016/j.cell.2014.02.030 · Cited by 944
Zhou, W., Ke, S. Q., Huang, Z., Flavahan, W., Fang, X., Paul, J., Wu, L., Sloan, A. E., McLendon, R. E., Li, X., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3090 · Cited by 940
Glioblastoma Stem Cells Generate Vascular Pericytes to Support Vessel Function and Tumor Growth
Cheng, L., Huang, Z., Zhou, W., Wu, Q., Donnola, S., Liu, J. K., Fang, X., Sloan, A. E., Mao, Y., Lathia, J. D., et al. (2013) · Cell · doi:10.1016/j.cell.2013.02.021 · Cited by 905
Self-citationPossible involvement of the M2 anti‐inflammatory macrophage phenotype in growth of human gliomas
Komohara, Y., Ohnishi, K., Kuratsu, J., & Takeya, M. (2008) · The Journal of Pathology · doi:10.1002/path.2370 · Cited by 738
Glioma cancer stem cells induce immunosuppressive macrophages/microglia
Wu, A., Wei, J., Kong, L.-Y., Wang, Y., Priebe, W., Qiao, W., Sawaya, R., & Heimberger, A. B. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq082 · Cited by 691
Macrophages and cancer: from mechanisms to therapeutic implications
Ostuni, R., Kratochvill, F., Murray, P. J., & Natoli, G. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.02.004 · Cited by 683
Wan, S., Zhao, E., Kryczek, I., Vatan, L., Sadovskaya, A., Ludema, G., Simeone, D. M., Zou, W., & Welling, T. H. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.08.039 · Cited by 675
The Yin‐Yang of tumor‐associated macrophages in neoplastic progression and immune surveillance
Allavena, P., Sica, A., Garlanda, C., & Mantovani, A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00607.x · Cited by 651
Evolving synergistic combinations of targeted immunotherapies to combat cancer
Melero, I., Berman, D. M., Aznar, M. A., Korman, A. J., Gracia, J. L. P., & Haanen, J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3973 · Cited by 637
Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors
Morello, A., Sadelain, M., & Adusumilli, P. S. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0583 · Cited by 477
Ye, X.-Z., Xu, S.-L., Xin, Y.-H., Yu, S.-C., Ping, Y.-F., Chen, L., Xiao, H.-L., Wang, B., Yi, L., Wang, Q.-L., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103248 · Cited by 477
Self-citationGünther, H. S., Schmidt, N. O., Phillips, H. S., Kemming, D., Kharbanda, S., Soriano, R., Modrusan, Z., Meissner, H., Westphal, M., & Lamszus, K. (2008) · Oncogene · doi:10.1038/sj.onc.1210949 · Cited by 443
Meng, K., Rodríguez-Peña, A., Dimitrov, T., Chen, W., Yamin, M., Noda, M., & Deuel, T. F. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.020487997 · Cited by 418
Mitsiadis, T. A., Salmivirta, M., Muramatsu, T., Muramatsu, H., Rauvala, H., Lehtonen, E., Jalkanen, M., & Thesleff, I. (1995) · Development · doi:10.1242/dev.121.1.37 · Cited by 292
Pleiotrophin regulates the expansion and regeneration of hematopoietic stem cells
Himburg, H. A., Muramoto, G. G., Daher, P., Meadows, S. K., Russell, J. L., Doan, P., Chi, J.-T., Salter, A. B., Lento, W. E., Reya, T., et al. (2010) · Nature Medicine · doi:10.1038/nm.2119 · Cited by 284
Wei, Y., Jiang, Y., Zou, F., Liu, Y., Wang, S., Xu, N., Xu, W., Cui, C., Xing, Y., Liu, Y., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217002110 · Cited by 274
Self-citationDeadly Teamwork: Neural Cancer Stem Cells and the Tumor Microenvironment
Lathia, J. D., Heddleston, J. M., Venere, M., & Rich, J. N. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.04.013 · Cited by 273
Self-citationGuryanova, O. A., Wu, Q., Cheng, L., Lathia, J. D., Huang, Z., Yang, J., MacSwords, J., Eyler, C. E., McLendon, R. E., Heddleston, J. M., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.03.004 · Cited by 260
Self-citationPleiotrophin: A Cytokine with Diverse Functions and a Novel Signaling Pathway
Deuel, T. F., Zhang, N., Yeh, H.-J., Silos-Santiago, I., & Wang, Z.-Y. (2002) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2705 · Cited by 235
Lu-Emerson, C., Snuderl, M., Kirkpatrick, N. D., Goveia, J., Davidson, C., Huang, Y., Riedemann, L., Taylor, J., Ivy, P., Duda, D. G., et al. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not082 · Cited by 226
Glioma Grade Is Associated with the Accumulation and Activity of Cells Bearing M2 Monocyte Markers
Prosniak, M., Harshyne, L. A., Andrews, D. W., Kenyon, L. C., Bedelbaeva, K., Apanasovich, T. V., Heber-Katz, E., Curtis, M. T., Cotzia, P., & Hooper, D. C. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1940 · Cited by 203
In vitro activation of a human macrophage-like cell line
KOREN, H. S., ANDERSON, S. J., & LARRICK, J. W. (1979) · Nature · doi:10.1038/279328a0 · Cited by 201
SPD--a web-based secreted protein database
Chen, Y. (2004) · Nucleic Acids Research · doi:10.1093/nar/gki093 · Cited by 192
Miao, H., Gale, N. W., Guo, H., Qian, J., Petty, A., Kaspar, J., Murphy, A. J., Valenzuela, D. M., Yancopoulos, G., Hambardzumyan, D., et al. (2015) · Oncogene · doi:10.1038/onc.2013.590 · Cited by 174
Self-citationMicroglial/macrophage expression of interleukin 10 in human glioblastomas
Wagner, S., Czub, S., Greif, M., Vince, G. H., S�ss, N., Kerkau, S., Rieckmann, P., Roggendorf, W., Roosen, K., & Tonn, J. C. (1999) · International Journal of Cancer · Cited by 149
Engineering strategies to mimic the glioblastoma microenvironment
Rape, A. D., Ananthanarayanan, B., & Kumar, S. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.08.012 · Cited by 138
Differential Induction of Glioblastoma Migration and Growth by Two Forms of Pleiotrophin
Lu, K. V., Jong, K. A., Kim, G., Singh, J., Dia, E. Q., Yoshimoto, K., Wang, M. Y., Cloughesy, T. F., Nelson, S. F., & Mischel, P. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502614200 · Cited by 133
Effect of miR-142-3p on the M2 Macrophage and Therapeutic Efficacy Against Murine Glioblastoma
Xu, S., Wei, J., Wang, F., Kong, L.-Y., Ling, X.-Y., Nduom, E. K.-E., Gabrusiewicz, K. R., Doucette, T. A., Yang, Y., Yaghi, N. K., et al. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju162 · Cited by 132
Wang, Z., Wang, B., Shi, Y., Xu, C. S., Xiao, H., N, L., Xu, S., Li, Y., Wang, Q.-S., Dang, W., et al. (2014) · Oncogene · doi:10.1038/onc.2014.75 · Cited by 131
Self-citationMartin‐Manso, G., Galli, S., Ridnour, L. A., Tsokos, M., Wink, D. A., & Roberts, D. D. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0643 · Cited by 130
Kawachi, H., Fujikawa, A., Maeda, N., & Noda, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041608698 · Cited by 107
Protein tyrosine phosphatase receptor type Z is inactivated by ligand‐induced oligomerization
Fukada, M., Fujikawa, A., Chow, J. P. H., Ikematsu, S., Sakuma, S., & Noda, M. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.06.041 · Cited by 91
Pariser, H. P., Ezquerra, L., Herradón, G., Pérez‐Piñera, P., & Deuel, T. F. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.05.007 · Cited by 91
Shi, Y., Zhou, W., Cheng, L., Chen, C., Huang, Z., Fang, X., Wu, Q., He, Z., Xu, S., Lathia, J. D., et al. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.110 · Cited by 86
Self-citationUlbricht, U., Brockmann, M. A., Aigner, A. M., Eckerich, C., Müller, S., Fillbrandt, R., Westphal, M., & Lamszus, K. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.12.1265 · Cited by 82
Yamashina, T., Baghdadi, M., Yoneda, A., Kinoshita, I., Suzu, S., Dosaka‐Akita, H., & Jinushi, M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2169 · Cited by 72
Grzelinski, M., Steinberg, F., Martens, T., Czubayko, F., Lamszus, K., & Aigner, A. M. (2009) · Neoplasia · doi:10.1593/neo.81040 · Cited by 68
Pleiotrophin Enhances Clonal Growth and Long-Term Expansion of Human Embryonic Stem Cells
Soh, B.-S., Song, C. M., Vallier, L., Li, P., Choong, C. S. N., Yeo, B. H., Lim, E. H., Pedersen, R. A., Yang, H. H., Rao, M. S., et al. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0372 · Cited by 68
Yokoi, H., Kasahara, M., Mori, K., Ogawa, Y., Kuwabara, T., Imamaki, H., Kawanishi, T., Koga, K., Ishii, A., Kato, Y. H., et al. (2011) · Kidney International · doi:10.1038/ki.2011.305 · Cited by 67
Roles of pleiotrophin in tumor growth and angiogenesis
Papadimitriou, Ε., Mikelis, C. M., Lampropoulou, E., Κουτσιούμπα, Μ., Theochari, K., Tsirmoula, S., Theodoropoulou, C., Λάμπρου, Μ., Sfaelou, E., Vourtsis, D., et al. (2009) · European Cytokine Network · doi:10.1684/ecn.2009.0172 · Cited by 65
ALK receptor activation, ligands and therapeutic targeting in glioblastoma and in other cancers
Wellstein, A. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00192 · Cited by 65
Chang, Y., Zuka, M., Pérez‐Piñera, P., Astudillo, A., Mortimer, J. E., Berenson, J. R., & Deuel, T. F. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704366104 · Cited by 65
Zhang, L., Kundu, S., Feenstra, T., Li, X., Jin, C., Laaniste, L., Hassan, T. E. A. E., Ohlin, K. E., Yu, D., Olofsson, T., et al. (2015) · Science Signaling · doi:10.1126/scisignal.aaa1690 · Cited by 63
Self-citationMolecular subtypes, stem cells and heterogeneity: Implications for personalised therapy in glioma
Morokoff, A. P., Ng, W., Gogos, A., & Kaye, A. H. (2015) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2015.02.008 · Cited by 55
miR-663 Suppresses Oncogenic Function of CXCR4 in Glioblastoma
Shi, Y., Chen, C., Yu, S., Liu, Q., Rao, J., Zhang, H., Xiao, H., Fu, T., Long, H., He, Z., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2807 · Cited by 54
Self-citationTherapeutically reeducating macrophages to treat GBM
Garris, C., & Pittet, M. J. (2013) · Nature Medicine · doi:10.1038/nm.3355 · Cited by 42
Michelotti, G. A., Tucker, A., Swiderska-Syn, M., Machado, M. V., Choi, S. S., Kruger, L., Soderblom, E., Thompson, J. W., Mayer-Salman, M., Himburg, H. A., et al. (2016) · Gut · doi:10.1136/gutjnl-2014-308176 · Cited by 40
Deininger, M. H., Pater, S., Strik, H. M., & Meyermann, R. (2001) · Journal of Neuro-Oncology · doi:10.1023/a:1013805915224 · Cited by 37
The pleiotrophin-ALK axis is required for tumorigenicity of glioblastoma stem cells
Koyama‐Nasu, R., Haruta, R., Nasu‐Nishimura, Y., Taniue, K., KATOU, Y., Shirahige, K., Todo, T., Ino, Y., Mukasa, A., Saito, N., et al. (2013) · Oncogene · doi:10.1038/onc.2013.168 · Cited by 37
Reciprocal Supportive Interplay between Glioblastoma and Tumor-Associated Macrophages
Zhou, W., & Bao, S. (2014) · Cancers · doi:10.3390/cancers6020723 · Cited by 34
Self-citationPleiotrophin is highly expressed by myeloma cells and promotes myeloma tumor growth
Chen, H., Gordon, M. S., Campbell, R. A., Li, M., Wang, C. S., Lee, H. J., Sanchez, E., Manyak, S. J., Gui, D., Shalitin, D., et al. (2007) · Blood · doi:10.1182/blood-2006-08-042374 · Cited by 27
Du, Z., Shi, M., Ji, C., & Yu, Y. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.4.1421 · Cited by 23
A receptor-type protein tyrosine phosphatase PTP zeta is expressed in human cutaneous melanomas.
Goldmann, T., Otto, F., & Vollmer, E. (2000) · PubMed · Cited by 18
Fyn arrests swainsonine-induced apoptosis in 293T cells via Akt and its phosphorylation
An, L., Li, W. W., & Cheng, G. (2015) · Genetics and Molecular Research · doi:10.4238/2015.may.18.23 · Cited by 7
Cited by
Targeting cancer stem cell pathways for cancer therapy
Yang, L., Shi, P., Zhao, G., Xu, J., Peng, W., Zhang, J., Zhang, G., Wang, X., Dong, Z., Chen, F., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0110-5 · Cited by 1,906
Self-citationFriebel, E., Kapolou, K., Unger, S., Núñez, N. G., Utz, S., Rushing, E. J., Regli, L., Weller, M., Greter, M., Tugues, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.055 · Cited by 685
Cancer stem cell–immune cell crosstalk in tumour progression
Bayik, D., & Lathia, J. D. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00366-w · Cited by 561
Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer
Gimple, R. C., Bhargava, S., Dixit, D., & Rich, J. N. (2019) · Genes & Development · doi:10.1101/gad.324301.119 · Cited by 514
Self-citationOuter Radial Glia-like Cancer Stem Cells Contribute to Heterogeneity of Glioblastoma
Bhaduri, A., Di Lullo, E., Jung, D., Müller, S., Crouch, E. E., Espinosa, C. S., Ozawa, T., Alvarado, B., Spatazza, J., Cadwell, C. R., et al. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2019.11.015 · Cited by 419
Metadata
- Authors
- Shi, Y., Ping, Y.-F., Zhou, W., He, Z.-C., Chen, C., Bian, B.-S.-J., Zhang, L., Chen, L., Lan, X., Zhang, X.-C., Zhou, K., Liu, Q., Long, H., Fu, T.-W., Zhang, X.-N., Cao, M.-F., Huang, Z., Fang, X., Wang, X., Feng, H., Yao, X.-H., Yu, S.-C., Cui, Y.-H., Zhang, X., Rich, J. N., Bao, S., & Bian, X.-W.
- Venue
- Nature Communications
- Published
- 2017-06-01
- Volume
- 8
- Issue
- 1
- Pages
- 15080-15080
- ISSN
- 2041-1723 (ISSN-L)
- OpenAlex
- W2620943949
- Cited by
- 344
- References
- 67
- FWCI
- 9.10
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
